FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sandoz Ephedrine Sulfate Injection Recall

Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01),…

Sandoz Inc · Princeton, NJ

Risk level
Class II
Reported by FDA
Sep 28, 2016
Recall ID
D-1513-2016
Check your lot numberHow we source this data

Summary

Sandoz recalled Ephedrine Sulfate Injection starting Aug 24, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1513-2016 on Sep 28, 2016. Reason: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Product description

Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Lot numbers, UPCs & expiration codes

Lot #: 080514, 080614, 081114, 081214, 081314, 081414, 082714, 082814, 082914, Exp 08/16; 090214, 090314, 090814, 090914, 091014, 091114, 091214, 091514, Exp 09/16

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1513-2016
Classification
Class II
Status
Terminated
Recall initiated
Aug 24, 2016
FDA report date
Sep 28, 2016
Quantity
32,099 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Inc

Original FDA data

Every field from FDA enforcement report D-1513-2016, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
75032
Address
100 College Rd W
Code information
Lot #: 080514, 080614, 081114, 081214, 081314, 081414, 082714, 082814, 082914, Exp 08/16; 090214, 090314, 090814, 090914, 091014, 091114, 091214, 091514, Exp 09/16
Postal code
08540-6604
Report date
Sep 28, 2016
Product type
Drugs
Recall number
D-1513-2016
Classification
Class II
Recalling firm
Sandoz Inc
Product quantity
32,099 cartons
Termination date
Jul 12, 2017
Reason for recall
Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Aug 24, 2016
Initial firm notification
Letter
Center classification date
Sep 19, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1513-2016, published Sep 28, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls